tiprankstipranks
Trending News
More News >
Sienna Biopharmaceuticals (SNNAQ)
OTHER OTC:SNNAQ
US Market

Sienna Biopharmaceuticals (SNNAQ) Income Statement

Compare
71 Followers

Sienna Biopharmaceuticals Income Statement

Last quarter (Q3 2019), Sienna Biopharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Sienna Biopharmaceuticals's net income was $-3.97M. See Sienna Biopharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 18Dec 17
Total Revenue
$ 0.00$ 0.00
Gross Profit
$ -157.00K$ -120.00K
Operating Expenses
$ 76.50M$ 48.57M
Depreciation and Amortization
$ 157.00K$ 120.00K
EBITDA
$ -76.34M$ -48.45M
Operating Income
$ -76.50M$ -48.57M
Other Income/Expenses
$ 3.03M$ -2.26M
Pretax Income
$ -73.47M$ -50.84M
Net Income
$ -73.31M$ -50.55M
Per Share Metrics
Basic EPS
$ -3.59$ -5.19
Diluted EPS
$ -3.59$ -5.19
Weighted Average Shares Outstanding
20.45M 9.73M
Weighted Average Shares Outstanding (Diluted)
20.45M 9.73M
Currency in USD

Sienna Biopharmaceuticals Earnings and Revenue History